Volume 18, 2014 Archive

Six issues from 2014 in one convenient archive.

This archive contains the following articles listed by volume, issue and page number:

Issue/Volume	Title
Issues Included
January/February 2014 Vol. 18 No. 1	Volume 18, Number 1
March/April 2014 Vol. 18 No. 2	Volume 18, Number 2
May/June 2014 Vol. 18 No. 3	Volume 18, Number 3
July/August 2014 Vol. 18 No. 4	Volume 18, Number 4
September/October 2014 Vol. 18 No. 5	Volume 18, Number 5
November/December 2014 Vol. 18 No. 6	Volume 18, Number 6

Volume 18, 2014 Articles

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2014 Pg. 4	PreScription: The International Journal of Pharmaceutical Compounding Begins Its 18th Year Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 6-12	The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013 Author(s): Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
Jan/Feb 2014 Pg. 14-19	Using Compounded Medications for the Topical Treatment of Complex Regional Pain Syndrome Type I Following Trauma: A Case Report Author(s): Zur Eyal
Jan/Feb 2014 Pg. 20-29	Good Enough for America Author(s): Worthen Dennis B
Jan/Feb 2014 Pg. 30-34	Determination of Risk for Sterile Preparations Author(s): Freedman ben-Horin Shimon, Rousso Tamaro
Jan/Feb 2014 Pg. 35-36	U.S. Food and Drug Administration Requests for Input on HR 3204 Enactment: The Drug Quality and Security Act of 2013 Author(s): Miller David G
Jan/Feb 2014 Pg. 38	Marketing Author(s): Moore Renee
Jan/Feb 2014 Pg. 42-45	Tips and Hints: Powders, Capsules, Tablets, Suppositories, and Sticks Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 46-52	Quality Control Analytical Methods: Laboratory Considerations of United States Pharmacopeia Chapter <71> Sterile Tests and Its Application to Pharmaceutical Compounding Author(s): Hyde Tiffany D
Jan/Feb 2014 Pg. 54-57	Basics of Sterile Compounding: Bubble Point Testing Author(s): Thoma Laura
Jan/Feb 2014 Pg. 58-59	Calculations Author(s): Stockton Shelly J
Jan/Feb 2014 Pg. 60	Aztreonam Injection Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 61	Bumetanide 0.25-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 62	Droperidol 2.5-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 63	Lomustine 100-mg Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 64	Neostigmine Bromide 15-mg Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 65	Nimodipine 30-mg Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 66	Phenobarbital 60-mg Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 67	Potassium Chloride 2-mEq/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 68	Procainamide Hydrochloride 100-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 69	Vasopressin 20-units/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 70-77	The Effectiveness of Sublingual and Topical Compounded Bioidentical Hormone Replacement Therapy in Post-menopausal Women: An Observational Cohort Study Author(s): Ruiz Andres D, Daniels Kelly R
Jan/Feb 2014 Pg. 78-82	Long-term Stability of Morphine Hydrochloride in 0.9% NaCl Infusion Polyolefin Bags After Freeze-thaw Treatment and in Polypropylene Syringes at 5°C ± 3°C Author(s): Hecq J-D, Godet M, Gillet P, Jamart J, Galanti L
Jan/Feb 2014 Pg. 83-86	E-Prescribing Errors Identified in a Compounding Pharmacy: A Quality-improvement Project Author(s): Reed-Kane Dana, Kittell Katrina, Adkins Jacquelyn, Flocks Sarah, Nguyen Thu
Jan/Feb 2014 Pg. 87	PostScription: Pharmacy Benefit Managers and Compounding Pharmacists: Billing for Services Author(s): Lees Deril J
Mar/Apr 2014 Pg. 92	PreScription: Standards vs Opinions Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 94-99	A Needle-free Reconstitution and Transfer System for Compounded Sterile Intravenous Drug Solutions: In Compliance with United States Pharmacopeia Chapter <797> Standards Author(s): Marks Zach
Mar/Apr 2014 Pg. 101-111	Pharmaceutical Compounding or Pharmaceutical Manufacturing? A Regulatory Perspective Author(s): Timko Robert J, Crooker Philip EM
Mar/Apr 2014 Pg. 112-116	Compounding Practices in Iran Author(s): Goodarzi Navid, Niknam Somayeh, Akbarzadeh Tahmineh, Gholami Kheirollah
Mar/Apr 2014 Pg. 117-118	IACP's Continuing Support of Compounding Pharmacists: Letter to the FDA Concerning 503B Outsourcing Facilities Author(s): Miller David G
Mar/Apr 2014 Pg. 120-121	Effective Advertisements Author(s): Moore Renee
Mar/Apr 2014 Pg. 123-130	Quality Control Analytical Methods: The Essentials of United States Pharmacopeia Chapter <51> Antimicrobial Effectiveness Testing and Its Application in Pharmaceutical Compounding Author(s): Vu Nicole, Nguyen Devin, Kupiec Thomas C
Mar/Apr 2014 Pg. 131-134	Basics of Sterile Compounding: Compounding by Weight Versus Compounding by Volume Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 137-138	Basics of Compounding: Tips and Hints, Part 2: Compounding with Solutions, Suspensions, Emulsions, and Lotions Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 140-141	Calculations Author(s): Stockton Shelly J
Mar/Apr 2014 Pg. 142	Doxazosin 1-mg, 2-mg, 4-mg, or 8-mg Capsules Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 143	Fludarabine Phosphate 25-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 144	Mecasermin 10-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 145	Methylprednisolone 40-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 146	Polymixin B Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 147	Rocuronium Bromide 10-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 148	Secretin 4 mcg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 149	Selenium 40-mcg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 150	Sincalide 1-mcg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 151	Testosterone Enanthate 200-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 152-158	Chemical and Physical Compatibility of an Intravenous Solution of Epinephrine with Calcium Chloride Author(s): Weeks Phillip A, Teng Yang, Wu Lei, Sun Mary, Yang Zhen, Chow Diana S-L
Mar/Apr 2014 Pg. 159-161	E-Prescription Errors and Their Resolution in a Community Compounding Pharmacy Author(s): Reed-Kane Dana, Vasquez Kellie, Pavlik Aaron, Pergine Johanna, Sandberg Michelle
Mar/Apr 2014 Pg. 162-168	The Standardization of Nonsterile Compounding: A Study in Quality Control and Assessment for Hormone Compounding Author(s): Wiley TS, Odegard RD, Raden J, Haraldsen JT
Mar/Apr 2014 Pg. 169-174	Preparation and Stability Evaluation of Extemporaneous Oral Suspension of Valsartan Using Commercially Available Tablets Author(s): Zaid Abdel Naser, Assali Mohyeddin, Qaddomi Aiman, Ghanem Mashhour, Zaaror Yara Abu
Mar/Apr 2014 Pg. 175	Recharting Your Vision While Remaining True to Your Charter Author(s): Hesterlee Edward J
May/Jun 2014 Pg. 180	PreScription: Déjà Vu All Over Again Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 182-188	A Brief Survey on Prescriber Beliefs Regarding Compounded Topical Pain Medications Author(s): Warner Meredith, Tuder Dmitry
May/Jun 2014 Pg. 190-200	Compounded Drugs of Value in Outpatient Hospice and Palliative Care Practice Author(s): McNulty John P, Muller George
May/Jun 2014 Pg. 203-207	Literature Review: The Dual Role of Domperidone in Gastroparesis and Lactation Author(s): Phan Ha, DeReese Annie, Day A J, Carvalho Maria
May/Jun 2014 Pg. 208	The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter Author(s): Miller David G
May/Jun 2014 Pg. 210-211	Marketing: Effective Use of Advertisements on Your Website Author(s): Moore Renee
May/Jun 2014 Pg. 213-221	Quality Control Analytical Methods: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 1 Author(s): Vu Nicole, Lou Jessica R, Kupiec Thomas
May/Jun 2014 Pg. 222-226	Quality Control Analytical Methods: Establishing Powder-handling Workflow Practices and Standard Operating Procedures: Compounding Pharmacy and Safety Author(s): Prince Bryan, Lundevall Jeremy
May/Jun 2014 Pg. 228-230	Basics of Compounding: Tips and Hints, Part 3: Compounding with Ointments, Creams, Pastes, Gels, and Gel-creams Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 231	Calculations Author(s): Stockton Shelly J, Saluja Hardeep Singh
May/Jun 2014 Pg. 232	Atorvastatin 10-mg or 20-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 233	Bumetanide 0.5-mg, 1-mg, or 2-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 234	Bupivacaine Hydrochloride 0.5% Injection Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 235	Butorphanol Tartrate 10-mg/mL Nasal Spray Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 236	Dibucaine 1% Ointment Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 237	Lidocaine Hydrochloride 1% Injection Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 238	Methotrexate 2.5-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 239	Naproxen 25-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 240	Tamoxifen 10-mg or 20-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 241	Thiothixene 1-mg, 2-mg, 5-mg, or 10-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 242-247	Examination of the Order of Incubation for the Recovery of Bacteria and Fungi from Pharmaceutical-grade Cleanrooms Author(s): Sandle Tim
May/Jun 2014 Pg. 248-252	Investigation of Physical and Chemical Stability of an Ointment with Herbals Author(s): Zdoryk Oleksandr A, Khokhlova Kateryna O, Georgiyants Victoriya A, Vyshnevska Liliia I
May/Jun 2014 Pg. 253-255	Evaluation of the Stability of Fluoxetine in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date Author(s): Peacock Gina F, Sauvageot Jurgita
May/Jun 2014 Pg. 256-261	Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery Author(s): Boddu Sai HS, Bonam Sindhu Prabha, Wei Yangjie, Alexander Kenneth
May/Jun 2014 Pg. 262-263	PostScription: The Fourth Annual Student Pharmacist Compounding Competition: Building Future Leaders in the Industry Author(s): Bastos Dea
Jul/Aug 2014 Pg. 268	PreScription: Challenging Times Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 270-276	Vial Washers for the Compounding Pharmacy: Ensuring Preparation Safety Author(s): Johnson Kain, Sully Andrew, Anthenat Bruce
Jul/Aug 2014 Pg. 278-286	Compounded Pain Formulations: What is the Evidence? Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Jul/Aug 2014 Pg. 287-290	Oral Mucosal Immunotherapy Using a Toothpaste Delivery System for the Treatment of Allergic Rhinitis Author(s): Reisacher William, Rudner Shara, Kotik Viktoriya
Jul/Aug 2014 Pg. 293-300	Color Additives: Legislative Perspective in the United States, Europe, Australia, and India Author(s): Kumar Anuj, Madan Anil K
Jul/Aug 2014 Pg. 302	400 Attendees Convene in Washington, D.C., for the 20th Annual Compounders on Capitol Hill Author(s): Miller David G
Jul/Aug 2014 Pg. 305-310	Quality Control: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 2 Author(s): Vu Nicole, Lou Jessica R, Kupiec Thomas C
Jul/Aug 2014 Pg. 313-317	Basics of Compounding Sterile Preparations: Nomenclature and Considerations Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 318-319	Basics of Compounding: Tips and Hints, Part 4: Lollipops/Lozenges, Gummy Bears, Patches, Flavoring/Coloring, Sweeteners, and Packaging Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 320-321	Calculations Author(s): Stockton Shelly J
Jul/Aug 2014 Pg. 322	Atracurium Besylate 10-mg/mL Injection, Preserved Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 323	Barium Sulfate Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 324	Calcitriol 1-mcg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 325	Chloramphenicol 100-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 326	Chlorothiazide 50-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 327	Choline Magnesium Trisalicylate Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 328	Denileukin Diftitox 150-mcg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 329	Indigo Carmine Injection Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 330	Propranolol Hydrochloride 1-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 331	Zinc 1-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 332-340	Evaluation of Percutaneous Absorption Performance for Human Female Sexual Steroids into Pentravan Cream Author(s): Polonini Hudson C, Brandão Marcos Antônio F, Ferreira Anderson O, Ramos Cristiano, Raposo Nádia R B
Jul/Aug 2014 Pg. 341-344	Assessing the Use of Food Coloring as an Appropriate Visual Guide for Homogenously Mixed Capsule Powders in Extemporaneous Compounding Author(s): Hoffmann Brittany, Carlson Christie, Rao Deepa A
Jul/Aug 2014 Pg. 345-347	Evaluation of the Stability of Promethazine Hydrochloride in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date Author(s): Peacock Gina F, Sauvageot Jurgita
Jul/Aug 2014 Pg. 348-350	Evaluation of the Stability of Ketoprofen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date Author(s): Peacock Gina F, Sauvageot Jurgita, Addo Richard T
Jul/Aug 2014 Pg. 351	PostScription: Responsibilities of a Compounding Pharmacist Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 356	PreScription: What is a Compounding Pharmacist? Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 358-364	Roboticized Compounding of Oncology Drugs in a Hospital Pharmacy Author(s): Palma Elisabetta, Bufarini Celestino
Sep/Oct 2014 Pg. 366-369	To Compound or Not to Compound: A Veterinary Transdermal Discussion Author(s): Eichstadt Lauren R, Davidson Gigi S
Sep/Oct 2014 Pg. 370-377	Autologous Serum Eye Drops for Severe Dry Eye Syndrome in a Patient with Chronic Graft-vs-Host Disease: A Case Report Author(s): Mixon Bill, Mixon Jan, Isbey Edward K III, Sprinkle Shari
Sep/Oct 2014 Pg. 379-380	Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A Author(s): Blankenship Cynthia E
Sep/Oct 2014 Pg. 382-391	Health Care in Belarus in the 19th and 20th Centuries Author(s): Tishchenko Evgenii Mikhailovich
Sep/Oct 2014 Pg. 392-395	Compounding Practices in a Portuguese Community Pharmacy Author(s): Reis Maria, Carvalho Maria, Rodrigues Angelo
Sep/Oct 2014 Pg. 397-399	Basics of Compounding: Certification of Sterile Equipment and Facilities: What Pharmacists Need to Know Author(s): Lanze Amanda, Rudner Shara
Sep/Oct 2014 Pg. 401-404	Basics of Compounding: Tips and Hints, Part 5: Facilities and Equipment Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 406	Marketing: Tips on Dealing With a Healthcare Practititioner's No-Rep Policy Author(s): Moore Renee
Sep/Oct 2014 Pg. 407	Calculations Author(s): Stockton Shelly J
Sep/Oct 2014 Pg. 408	Azithromycin 100-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 409	Bacitracin Topical Ointment Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 410	Dexpanthenol 250-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 411	Ephedrine Sulfate 50-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 412	Fluorescein 100-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 413	Indocyanine green 2.5-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 414	Phenylephrine Hydrochloride 2.5%-Ophthalmic Solution Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 415	Sulfamethoxazole and Trimethoprim Oral Solution Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 416	Sumatriptan Succinate 12-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 417	Tranexamic Acid 100-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 418-426	Stability and In Vitro Toxicity of an Infliximab Eye Drop Formulation Author(s): Robert Marie-Claude, Spurr-Michaud Sandra, Frenette Mathieu, Young David, Gipson Ilene K, Dohlman Claes H
Sep/Oct 2014 Pg. 427-431	Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition Author(s): Bourget Philippe, Amin Alexandre, Vidal Fabrice, Pieyre Manon, Dosso El Ourmar, Beauvais Raphaelle, Loeuillet Richard
Sep/Oct 2014 Pg. 432-437	Stability of Tranexamic Acid in 0.9% Sodium Chloride, Stored in Type 1 Glass Vials and Ethylene/Propylene Copolymer Plastic Containers Author(s): McCluskey Susan V, Sztajnkrycer Matthew D, Jenkins Donald A, Zietlow Scott P, Berns Kathleen S, Park Myung S
Sep/Oct 2014 Pg. 438-439	PostScription: The Future of Veterinary Compounding Author(s): Jordan Dinah G
Nov/Dec 2014 Pg. 444	PreScription: "Named Formulas" Database Available Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 446-454	Depyrogenation Options for the Compounding Cleanroom Author(s): Weller Tom, Bell Jeff, Dullinger Roger, Allen Vern, Anthenat Bruce
Nov/Dec 2014 Pg. 456-460	Standards of Practice, Professional Judgment, and Scientific Evidence to Establish and Extend a Beyond-Use Date Author(s): Thomson Cassandra Marie, Savji Taslim
Nov/Dec 2014 Pg. 462-468	Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Medications in a Rural Setting: A Case Study from the Delmarva Peninsula Author(s): Sherr Zachary, Karara Adel H
Nov/Dec 2014 Pg. 470-472	Compounding Legislation: Focus Shifts to States Author(s): Miller David G
Nov/Dec 2014 Pg. 475-477	Quality Control: Can Compounding Pharmacy Learn from the Automotive Industry? Author(s): Dillon L Rad
Nov/Dec 2014 Pg. 479-484	Basics of Compounding: Unique and Special Characteristics of Sterile Dosage Forms Author(s): Akers Michael J
Nov/Dec 2014 Pg. 486-488	Basics of Compounding: Tips and Hints, Part 6: Prescription Evaluation, Calculations, Ingredients, Quality-Assurance Practices, Patient Counseling, Shipping and Distribution, Miscellaneous Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 490-491	Marketing: Using Facebook to Market Your Compounding Pharmacy Author(s): Moore Renee
Nov/Dec 2014 Pg. 492-493	Calculations Author(s): Stockton Shelly J
Nov/Dec 2014 Pg. 494	Clarithromycin 250-mg or 500-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 495	Dexmedetomidine 100 mcg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 496	Dexmethylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 497	Leucovorin 10-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 498	Levocarnitine 200-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 499	Methazolamide 25-mg or 50-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 500	Methylene Blue 10-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 501	Methylphenidate Hydrochloride 10-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 502	Oxacillin Sodium 167-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 503	Tamsulosin Hydrochloride 0.2-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 504-511	Skin Penetration and Antinociception of Topical Gabapentin Formulations Author(s): Bryson Evan, Asbill Scott, Sweitzer Sarah
Nov/Dec 2014 Pg. 512-515	In Vitro Skin Penetration and Skin Content of Progesterone from Various Topical Formulations Author(s): Heustess Allie, Asbill Scott, Eagerton David, Arnold John
Nov/Dec 2014 Pg. 516-519	Effect of Emulsifier Pairs on Physical Stability of Emulsions Containing Three Different Natural Oils Author(s): Boonme Prapaporn, Maneenuan Duangkhae
Nov/Dec 2014 Pg. 520-525	High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products Author(s): Quamrun Masuda, Mamoon Rashid, Nasheed Shams, Mullins Randy
Nov/Dec 2014 Pg. 526-527	PostScription: Pharmacy Compounding Accreditation Board: Past, Present, and Future Author(s): Cabaleiro Joe